Based on the results of this study, we propose for the first time that STMN1 is involved with the process of IDD and that inhibition of the STMN1–IGFBP5 axis can reduce NP cell senescence and ECM degradation, providing a potential therapeutic target for IDD treatment. Here, IGFBP5 is linked to intervertebral disk degenerative disorder.